- The Effect of Smoking Status upon Occurrence of Impaired Fasting Glucose or Type 2 Diabetes in Korean Men.
-
Chang Hae Park, Hyuk Ga, Jong Han Leem, Seung Min Kwak, Hwan Cheol Kim, Ji Ho Choi
-
J Prev Med Public Health. 2008;41(4):249-254.
-
DOI: https://doi.org/10.3961/jpmph.2008.41.4.249
-
-
5,107
View
-
68
Download
-
8
Crossref
-
 Abstract
 PDF
- OBJECTIVES
To investigate whether smoking and the smoking status are predictors of the incident impaired fasting glucose (IFG) or type 2 diabetes in Korean men. METHODS: A cohort of 1,717 Korean men without IFG or diabetes, who underwent annual periodic health examinations for 4 years (2002-2006), were retrospectively investigated. IFG and diabetes were defined as a serum fasting glucose concentration of 100-125 mg/dL and more than 126 mg/dL, respectively. Cox's proportional hazards model was used to evaluate the association between smoking and development of IFG or type 2 diabetes. RESULTS: A total of 558 cases (32.5%) of incident IFG and 50 cases (2.9%) of diabetes occurred. After controlling for the potential predictors of diabetes, the relative risk for IFG, compared with the never smokers, was 1.02 (95% CI=0.88 to 1.19) for the ever-smokers, 0.96 (95% CI=0.79-1.16) for those who smoked 1-9 cigarettes/d, 1.15 (95% CI=1.01 to 1.30) for those who smoked 10-19 cigarettes/d, and 1.31 (95% CI=1.10 to 1.57) for those who smoked 20 or more cigarettes/d (the P value for the current smokers was only p<0.002). The respective multivariate adjusted relative risks for type 2 diabetes, compared with the neversmokers, were 1.07 (95% CI=0.64 to 1.92), 1.47 (95% CI=0.71 to 3.04), 1.84 (95% CI=0.92-3.04), and 1.87 (95% CI=1.13-3.67), respectively (the P value for the current smokers was only p=0.004). CONCLUSIONS: The smoking status and the number of cigarettes smoked daily are associated with an increased risk for developing IFG or type 2 diabetes in Korean men.
-
Summary
-
Citations
Citations to this article as recorded by  - Health effects associated with smoking: a Burden of Proof study
Xiaochen Dai, Gabriela F. Gil, Marissa B. Reitsma, Noah S. Ahmad, Jason A. Anderson, Catherine Bisignano, Sinclair Carr, Rachel Feldman, Simon I. Hay, Jiawei He, Vincent Iannucci, Hilary R. Lawlor, Matthew J. Malloy, Laurie B. Marczak, Susan A. McLaughlin
Nature Medicine.2022; 28(10): 2045. CrossRef - Systematic review with meta-analysis of the epidemiological evidence relating smoking to type 2 diabetes
Peter N Lee, Katharine J Coombs
World Journal of Meta-Analysis.2020; 8(2): 119. CrossRef - The 2016 global and national burden of diabetes mellitus attributable to PM 2·5 air pollution
Benjamin Bowe, Yan Xie, Tingting Li, Yan Yan, Hong Xian, Ziyad Al-Aly
The Lancet Planetary Health.2018; 2(7): e301. CrossRef - The impact of smoking on the development of diabetes and its complications
Mariola Śliwińska-Mossoń, Halina Milnerowicz
Diabetes and Vascular Disease Research.2017; 14(4): 265. CrossRef - Effects of Nutrition Education on Improvement of Blood Glucose in Type 2 Diabetic Patients with Low Income
Eun-Jin Lim, Mi Jeong Kim, Ji-Sook Han
Journal of the Korean Society of Food Science and Nutrition.2014; 43(1): 141. CrossRef - Associated Factors of Impaired Fasting Glucose in Some Korean Rural Adults
Hye Eun Yun, Mi-ah Han, Ki Soon Kim, Jong Park, Myeng Guen Kang, So Yeon Ryu
Journal of Preventive Medicine and Public Health.2010; 43(4): 309. CrossRef - Association of passive and active smoking with incident type 2 diabetes mellitus in the elderly population: the KORA S4/F4 cohort study
Bernd Kowall, Wolfgang Rathmann, Klaus Strassburger, Margit Heier, Rolf Holle, Barbara Thorand, Guido Giani, Annette Peters, Christine Meisinger
European Journal of Epidemiology.2010; 25(6): 393. CrossRef - Diabetes and impaired fasting glucose in Mongolian population, Inner Mongolia, China
Shaoyan Zhang, Weijun Tong, Tan Xu, Burenbatu Wu, Yonghong Zhang
Diabetes Research and Clinical Practice.2009; 86(2): 124. CrossRef
- A Study of Immune Response to Hepatitis B Vaccine & HBV DNA in Isolated Anti-HBc Positive Subjects.
-
Hee Jeong Koh, Soon Duck Kim, Ji Ho Choi, Sung Ryul Kim, Jin Soo Lee
-
J Prev Med Public Health. 2005;38(2):170-174.
-
-
-
Abstract
PDF
- OBJECTIVES
The aim of this study was to evaluate the response to a hepatitis B vaccination, and investigate the HBV DNA in subjects with isolated anti-HBc. METHODS: 34 subjects with persistent isolated anti-HBc were included in the study. 32 subjects negative for HBsAg, anti-HBs and anti-HBc were included as a control group. They were all vaccinated with Hepaccine at 0, 1 and 2 months, and anti-HBs titers were measured 1 month after the 1st and 3rd vaccinations (1 and 3 months). The HBV-DNA was tested by polymerase chain reaction in subjects with isolated anti-HBc. RESULTS: After the 1st & 3rd vaccinations, the anti-HBs titers > or =10mIU/ml were 70.6 & 70.6% in isolated anti-HBc group, and 34.4 & 81.2% in the control group, respectively. There were statistically significant differences after the 1st vaccination, but none after the 3rd, between the two groups. In the isolated anti-HBc and control groups, the primary, amnestic and no responses were 0 vs. 46.9%, 55.9 vs. 6.3% and 29.4 vs. 18.8%, respectively. The HBV DNA was not detected in all subjects with isolated anti-HBc. CONCLUSION: None of the subjects with isolated anti-HBc had a false positive result (primary response) ; therefore, they should be excluded from vaccination programs in Korea. To differentiate between immunity and occult infections, a single dose of vaccine, with a follow-up anti- HBs test, is preferable for subjects with isolated anti-HBc. An amnestic response indicates late immunity, and no response a suspect occult infection.
-
Summary
|
KSPM
